FDx Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,206
Closed -$311K 448
2023
Q4
$311K Sell
4,206
-520
-11% -$34.1K 0.02% 520
2023
Q3
$322K Sell
4,726
-4,601
-49% -$390K 0.03% 451
2023
Q2
$876K Sell
9,327
-7,497
-45% -$585K 0.05% 331
2023
Q1
$833K Hold
16,824
0.04% 332
2022
Q4
$833K Buy
16,824
+3,658
+28% +$149K 0.04% 332
2022
Q3
$428K Sell
13,166
-530
-4% -$21.9K 0.02% 443
2022
Q2
$539K Sell
13,696
-414
-3% -$22.1K 0.02% 456
2022
Q1
$987K Buy
14,110
+4,087
+41% +$299K 0.03% 329
2021
Q4
$780K Buy
10,023
+788
+9% +$69.5K 0.02% 417
2021
Q3
$881K Buy
9,235
+1,301
+16% +$137K 0.03% 364
2021
Q2
$986K Buy
7,934
+1,415
+22% +$169K 0.03% 340
2021
Q1
$859K Buy
6,519
+1,054
+19% +$144K 0.03% 328
2020
Q4
$724K Buy
+5,465
New +$661K 0.03% 347
2020
Q1
Sell
-3,912
Closed -$362K 554
2019
Q4
$362K Buy
3,912
+302
+8% +$26.6K 0.02% 435
2019
Q3
$326K Buy
+3,610
New +$411K 0.02% 456
2017
Q2
Sell
-12,631
Closed -$298K 1199
2017
Q1
$298K Sell
12,631
-2,173
-15% -$43.1K 0.01% 974
2016
Q4
$198K Buy
14,804
+1,858
+14% +$30K 0.01% 1087
2016
Q3
$240K Buy
+12,946
New +$228K 0.01% 831

Other funds holding EXAS

FDx Advisors's EXAS Position: Q1 2024 in Review

FDx Advisors sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 4,206 shares — an estimated $311K sold.

FDx Advisors first reported a position in EXAS in Q3 2016 and held it in 18 quarters. The position peaked at $987K in Q1 2022. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • FDx Advisors reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • FDx Advisors sold 4,206 Exact Sciences shares in Q1 2024, an estimated $311K.
  • FDx Advisors first reported a position in Exact Sciences in Q3 2016 and held it in 18 quarters.
  • FDx Advisors's Exact Sciences position peaked at $987K in Q1 2022.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on FDx Advisors's 13F filing for Q1 2024, filed 3 May 2024.